PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pacific Biosciences Of California, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2012 to Q2 2024.
  • Pacific Biosciences Of California, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $17.2M, a 3.76% decline year-over-year.
  • Pacific Biosciences Of California, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $73M, a 0.39% increase year-over-year.
  • Pacific Biosciences Of California, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $72.1M, a 8.26% decline from 2022.
  • Pacific Biosciences Of California, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $78.6M, a 2.62% decline from 2021.
  • Pacific Biosciences Of California, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $80.7M, a 360% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $73M $17.2M -$672K -3.76% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $73.7M $19.5M +$1.57M +8.76% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $72.1M $16.6M -$1.37M -7.64% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $73.5M $19.7M +$755K +3.99% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $72.7M $17.9M -$1.13M -5.93% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $73.9M $18M -$4.75M -20.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $78.6M $18M -$983K -5.19% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $79.6M $18.9M -$16.9M -47.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $96.5M $19M +$3.21M +20.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $93.3M $22.7M +$12.5M +123% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $80.7M $18.9M +$13.7M +259% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $67.1M $35.8M +$30.8M +618% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $36.2M $15.8M +$12.6M +389% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $23.7M $10.2M +$6.13M +152% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $17.5M $5.28M +$1.41M +36.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $16.1M $4.99M +$930K +22.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $15.2M $3.23M -$855K -20.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $16.1M $4.03M -$349K -7.97% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $16.4M $3.87M -$3.65M -48.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $20.1M $4.06M -$1.06M -20.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $21.1M $4.09M -$1.14M -21.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $22.3M $4.38M -$901K -17.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $23.2M $7.52M +$2.13M +39.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $21M $5.13M +$157K +3.16% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $20.9M $5.22M +$215K +4.29% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $20.7M $5.28M +$298K +5.98% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $20.4M $5.39M +$555K +11.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $19.8M $4.97M -$139K -2.72% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $19.9M $5.01M -$29K -0.58% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $20M $4.98M +$403K +8.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $19.6M $4.84M +$809K +20.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $18.8M $5.11M +$1.87M +57.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $16.9M $5.04M +$1.72M +51.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $15.2M $4.58M +$1.33M +40.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $13.8M $4.03M +$1.03M +34.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $12.8M $3.24M +$786K +32.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $12M $3.32M +$1.1M +49.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $10.9M $3.26M +$985K +43.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $9.94M $3M +$455K +17.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 $9.49M $2.45M +$281K +12.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $9.21M $2.22M -$222K -9.08% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $9.43M $2.27M -$476K -17.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $9.91M $2.54M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 $2.17M -$217K -9.09% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $2.44M -$139K -5.38% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $2.75M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q3 2012 $2.39M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $2.58M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.